Urodynamics of Suprasacral Spinal Cord Injury Patients

Sponsor
Second Affiliated Hospital of Wenzhou Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT04642170
Collaborator
(none)
101
47.6

Study Details

Study Description

Brief Summary

The medical records of 215 patients with spinal cord injury(SCI) at the Department of Rehabilitation Medicine of the 2nd Affiliated Hospital of Wenzhou Medical University, Wenzhou, China were evaluated between January 1, 2016 and December 20, 2019. According to the inclusion criteria and exclusion criteria, 101 patients were included. The patients were dichotomized into two groups: complete SCI group and incomplete SCI group, based on the American Spinal Injury Association Guidelines Impairment Scale (AIS) .The investigators retrospectively collected records of urodynamic evaluations of this patients and then analyze the urodynamic parameters,including detrusor overactivity (DO), bladder compliance (BC), bladder-filling sensation, maximum cystometric capacity (MCC), detrusor external sphincter dyssynergia (DESD), maximum urinary flow rate (Qmax), detrusor pressure at a maximum urinary flow rate(PdetQmax).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    101 participants
    Observational Model:
    Case-Control
    Time Perspective:
    Retrospective
    Official Title:
    Urodynamic Findings in Patients With Complete and Incomplete Suprasacral Spinal Cord Injury at Different Stages After Injury
    Actual Study Start Date :
    Jan 1, 2016
    Actual Primary Completion Date :
    Dec 20, 2019
    Actual Study Completion Date :
    Dec 20, 2019

    Outcome Measures

    Primary Outcome Measures

    1. detrusor overactivity (DO) [0-365 days after injury]

      detrusor overactivity in milliliter,one of the urodynamic parameters

    2. bladder compliance (BC) [0-365 days after injury]

      bladder compliance in ml/cmH2O,one of the urodynamic parameters

    3. bladder-filling sensation [0-365 days after injury]

      bladder-filling sensation,one of the urodynamic parameters

    Secondary Outcome Measures

    1. maximum cystometric capacity (MCC) [0-365 days after injury]

      maximum cystometric capacity in milliliter,one of the urodynamic parameters

    2. detrusor external sphincter dyssynergia (DESD) [0-365 days after injury]

      detrusor external sphincter dyssynergia,one of the urodynamic parameters

    Other Outcome Measures

    1. maximum urinary flow rate (Qmax) [0-365 days after injury]

      maximum urinary flow rate in milliliter/second,one of the urodynamic parameters

    2. detrusor pressure at a maximum urinary flow rate(PdetQmax) [0-365 days after injury]

      detrusor pressure at a maximum urinary flow rate in cmH2O,one of the urodynamic parameters

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 80 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion criteria were:
    1. the period of the spinal shock has passed.

    2. patients diagnosed with traumatic suprasacral SCI, based on AIS.

    3. urodynamic investigations were performed by the same urologist.

    4. patients with voiding dysfunction.

    Exclusion Criteria:

    The patient with voiding dysfunction before the injury were excluded.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Second Affiliated Hospital of Wenzhou Medical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Junyan Lu, Attending doctor, Second Affiliated Hospital of Wenzhou Medical University
    ClinicalTrials.gov Identifier:
    NCT04642170
    Other Study ID Numbers:
    • SAHoWMU-CR2020-15-212
    First Posted:
    Nov 24, 2020
    Last Update Posted:
    Nov 24, 2020
    Last Verified:
    Nov 1, 2020
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Nov 24, 2020